- Home
- SPCE vs LRMR Comparison
SPCE vs LRMR Comparison
Compare SPCE & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCE
- LRMR
- Stock Information
- Founded
- SPCE 2017
- LRMR N/A
- Country
- SPCE United States
- LRMR United States
- Employees
- SPCE N/A
- LRMR N/A
- Industry
- SPCE Transportation Services
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- SPCE Consumer Discretionary
- LRMR Health Care
- Exchange
- SPCE Nasdaq
- LRMR Nasdaq
- Market Cap
- SPCE 187.1M
- LRMR 183.8M
- IPO Year
- SPCE N/A
- LRMR N/A
- Fundamental
- Price
- SPCE $3.11
- LRMR $1.88
- Analyst Decision
- SPCE Hold
- LRMR Strong Buy
- Analyst Count
- SPCE 5
- LRMR 9
- Target Price
- SPCE $19.85
- LRMR $19.00
- AVG Volume (30 Days)
- SPCE 1.3M
- LRMR 1.5M
- Earning Date
- SPCE 05-15-2025
- LRMR 04-30-2025
- Dividend Yield
- SPCE N/A
- LRMR N/A
- EPS Growth
- SPCE N/A
- LRMR N/A
- EPS
- SPCE N/A
- LRMR N/A
- Revenue
- SPCE $7,036,000.00
- LRMR N/A
- Revenue This Year
- SPCE N/A
- LRMR N/A
- Revenue Next Year
- SPCE $5,510.36
- LRMR N/A
- P/E Ratio
- SPCE N/A
- LRMR N/A
- Revenue Growth
- SPCE 3.47
- LRMR N/A
- 52 Week Low
- SPCE $2.18
- LRMR $1.61
- 52 Week High
- SPCE $28.20
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- SPCE 55.18
- LRMR 39.41
- Support Level
- SPCE $2.79
- LRMR $2.03
- Resistance Level
- SPCE $3.33
- LRMR $2.33
- Average True Range (ATR)
- SPCE 0.17
- LRMR 0.27
- MACD
- SPCE 0.06
- LRMR -0.05
- Stochastic Oscillator
- SPCE 62.07
- LRMR 2.04
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.